|
Friday 20th September 2024 |
Text too small? |
Tairawhiti, New Zealand – Rua Bioscience (NZX: RUA ) has decided to place new shares with key shareholders as part of a capital raise aimed at meeting short-term working capital requirements.
The company has secured $150,000 through this targeted raise.
This is part of Rua Bioscience’s broader financial strategy to ensure sufficient cash flow for its immediate needs while continuing to execute its growth plans in key markets. The funds will bridge the gap until the finalisation of the recent manufacturing facility sale, allowing Rua to focus on scaling its sales efforts in key international markets, particularly Germany, Australia and UK.
Chair Anna Stove stated, “This capital raise demonstrates the strong backing from our core shareholders and their confidence in Rua’s strategic direction. It enables us to maintain our operational momentum and ensure we have the necessary resources to meet our immediate working capital needs as we drive significant sales growth and sustainable revenue in FY25.”
ENDS
No comments yet
SKC - FY26 Half Year Result Teleconference Details
January 22nd Morning Report
TGG - FY 2025 Earnings Guidance Update
Meridian Energy monthly operating report for December 2025
January 21st Morning Report
PEB - Q3 26 Results and Key Strategic Milestones
FBU - Fletcher Building announces sale of Fletcher Construction
A thank you from Stuff's owner and publisher
FPH Appoints New Director and Future Director
January 19th Morning Report